top of page
Gorlin companies (9)_edited.png
iStock-154210279.jpg

Meet Our Executive Team

At the intersection of science, capital, and human impact, together, we create companies that move bold ideas from the lab to the world.   

Gorlin companies (2).png

Led by Principles. Guided by Vision.

Our team brings together accomplished leaders from healthcare, science, and finance, united by a shared mission to translate breakthrough ideas into real-world impact. Guided by visionary entrepreneur Steve Gorlin, we share a commitment to advancing science that improves global health and creates lasting value.

Over decades, Steve has cultivated an incomparable network of colleagues, collaborators, and friends, from world-renowned scientists and physicians to seasoned investors and industry pioneers, who form the foundation of the Gorlin ecosystem. With a keen eye for identifying promising science and exceptional founders, Steve has consistently recognized transformative potential long before it reaches the mainstream. Together, we combine deep scientific insight with strategic capital to accelerate innovation and bring meaningful advancements in patient care to life.

Our Dedicated Team

Each asset class at Loci is led by a managing principal with deep domain knowledge, allowing the firm to shift strategies dynamically, underwrite with precision, and add value at the asset level. With roots in Wall Street and experience on the ground, the team’s unified mission is to consistently outperform while remaining aligned and transparent with its investors.

Loci Capital is headquartered in Tampa with a second office in New Jersey and has become a trusted platform for sophisticated real estate investment across the Southeast United States.

Leadership

Our Dedicated Team

t43lhvsdasljgvfl26ia.avif

Steve Gorlin

Principal & Founder

Steve Gorlin is a visionary entrepreneur and investor with a prolific career spanning over 50 years. He has founded and built some of the most influential companies in biotech, pharmaceuticals, and technology. His extensive portfolio includes Hycor Biomedical (acquired by Agilent), Theragenics Corporation (NYSE: TGX). CytRx Corporation (NASDAQ: CYTR), Medicis Pharmaceutical Corporation (sold to Valeant for approximately $2.6 billion), EntreMed, Inc. (NASDAQ: ENMD), MRI Interventions (MRIC), DARA BioSciences, Inc. (NASDAQ: DARA), MiMedx (NASDAQ: MDXG), and Medivation, Inc. (NASDAQ: MDVN), which was acquired by Pfizer for $14 billion. He also founded Conkwest, which later became NantKwest (NASDAQ: NK), achieving the largest biotech IPO at the time with a market cap of $2.6 billion. Steve has launched several non-medical companies, including Perma-Fix Environmental Services (NASDAQ: PESI), Pretty Good Privacy, Inc. (sold to Network Associates), Judicial Correction Services, Inc. (sold to Correctional Healthcare), and NTC China. He is the President and Vice Chairman of CoRegen, Inc., leading the charge in transformative cell-based cancer therapies. He also serves as Chairman of the Board at C-Polar Technologies, Inc., which is redefining pathogen control with cutting-edge antimicrobial polymers. As Founder and Board Member of Oxia, Inc., he is advancing next-generation small-molecule drugs that unlock the body’s ability to repair and heal. He also founded IONOX, Inc., pushing the boundaries of performance and sustainability in lithium-ion battery technology. In addition, he is the founder and principal investor in SENVI, pioneering peptide therapeutics that target senescent cells to combat degenerative disease. He brings decades of entrepreneurial experience to these companies, helping to drive innovation and growth. Steve has served on numerous advisory boards, including the Business Advisory Council to the Johns Hopkins School of Medicine, the Johns Hopkins Biomedical Engineering Advisory Board, and the Board of the Andrews Institute. He currently sits on the Research Institute Advisory Committee (RIAC) of Massachusetts General Hospital. Deeply committed to giving back, he founded The Touch Foundation to support the blind and was a key financial contributor to the launch of Camp Kudzu, a camp for children living with diabetes.
photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

John Thomas

CFO

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

Steph Cence

Executive Partner

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

Michael Mansour, MD, PhD

Chief Science Officer

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

Leon Hebert, JD, MBA

Senior Advisor, Business and Legal Affairs

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

Franklyn Prendergast, MD, PhD

Director Emeritus

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

Keon Zhang

Strategic Marketing Advisor

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

Elena Ulansky

Managing Partner

photo-1633332755192-727a05c4013d_q=80&w=1480&auto=format&fit=crop&ixlib=rb-4_edited.png

John Mogford, PhD

Defense Science & Technology Advisor

bottom of page